Search Results 91-100 of 17216 for Erythema

  1. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

    The development of erythema nodosum if characterized by a desquamating rash while taking thalidomide or similar drugs; Patients with of history of any other ...

  2. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

    The development of erythema nodosum if characterized by a desquamating rash while taking thalidomide or similar drugs. Uncontrolled infection. Therapy with ...

  3. (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer - Mayo Clinic

    Bilateral invasive breast cancer; Inflammatory breast cancer defined as clinically significant erythema of the breast and/or documented dermal lymphatic ...

  4. Sun damage - Mayo Clinic

    Uneven pigmentation. To protect itself from the damaging effects of the sun, skin makes more brown pigment, called melanin. · Damage to brown or Black skin.

  5. Study of Pomalidomide for Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma and Newly Diagnosed or Relapsed/Refractory Intraocular Lymphoma - Mayo Clinic

    Men or women of childbearing potential who are unwilling to employ adequate contraception. The development of erythema nodosum if characterized by a ...

  6. Tirbanibulin (topical application route) - Side effects & dosage - Mayo Clinic

    Tirbanibulin topical is used to treat actinic keratosis on the face or scalp. This medicine is available only with your doctor's prescription. This product is ...

  7. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant - Mayo Clinic

    Participant has a history of severe cutaneous reaction, such as Steven-Johnson Syndrome (SJS), erythema multiforme (EM), Toxic Epidermal Necrolysis (TEN) or ...

  8. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

    Patients must have characteristic clinical features of BP (e.g., urticarial or eczematous or erythematous plaques, bullae, pruritus) at the screening and ...

  9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Patient has a history of severe cutaneous reactions like Stevens-Johnson-Syndrome (SJS), Erythema Multiforme (EM), Toxic Epidermal Necrolysis (TEN) or Drug ...

  10. Immune thrombocytopenia (ITP) - Symptoms and causes - Mayo Clinic

    Low levels of the cells that help blood clot, also known as platelets, most often cause the bleeding. Once known as idiopathic thrombocytopenic purpura, ITP can ...